Literature DB >> 6784425

Oestrogen-like effects of tamoxifen on the concentration of proteins in plasma.

G Fex, G Adielsson, W Mattson.   

Abstract

The concentrations of 11 plasma proteins were determined by electroimmunoassay in 6 female and one male patient before and after treatment for 1-4 months with tamoxifen (30 mg/day) for advanced cancer. The concentrations of transcortin, sex hormone binding globulin, pregnancy zone protein, apolipoprotein AI and thyroxine binding globulin increased significantly. The concentrations of orosomucoid and haptoglobin decreased significantly. The concentration of albumin, transferrin, prealbumin and retinol-binding protein showed no significant change. The changes after treatment with tamoxifen were thus similar to those which occur after the administration of oestrogens or during pregnancy although they were quantitatively less pronounced. There were also differences in the pattern of change between treatment with tamoxifen and during pregnancy. There was no apparent relationship between response to treatment and changes in concentration of plasma proteins.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6784425     DOI: 10.1530/acta.0.0970109

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  10 in total

Review 1.  Long-term adjuvant tamoxifen therapy for breast cancer.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1990-05       Impact factor: 4.872

Review 2.  Tamoxifen and mastalgia. An emerging indication.

Authors:  I S Fentiman
Journal:  Drugs       Date:  1986-12       Impact factor: 9.546

Review 3.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

Review 4.  Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

Review 5.  Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

6.  Steroid receptors and human endometrial carcinoma: studies in a nude mouse model.

Authors:  P G Satyaswaroop; R J Zaino; R Mortel
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

7.  Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancer.

Authors:  S I Helle; J Geisler; G B Anker; B Leirvaag; J M Holly; P E Lønning
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

8.  Influence of the antioestrogen tamoxifen on normal breast tissue.

Authors:  K J Walker; J M Price-Thomas; W Candlish; R I Nicholson
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

9.  Tamoxifen, serum lipoproteins and cardiovascular risk.

Authors:  P F Bruning; J M Bonfrer; A A Hart; M de Jong-Bakker; D Linders; J van Loon; W J Nooyen
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

10.  Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women.

Authors:  A L Jones; T J Powles; J G Treleaven; J F Burman; M C Nicolson; H I Chung; S E Ashley
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.